Cancer cells surround themselves with a cloud of adenosine, - thereby inhibiting the immune system (left). Ceritinib stops the formation of adenosine. ATP accumulates and activates immune cells (right).
Already approved drug could pave way to new pharmaceuticals, study by University of Bonn shows. Cancer cells surround themselves with a cloud of adenosine, - thereby inhibiting the immune system ( left ). Ceritinib stops the formation of adenosine. ATP accumulates and activates immune cells ( right ). Figure: Laura Schäkel/University of Bonn - created with BioRender.com . Many tumor cells mist themselves with a protective perfume that disables the immune system. But a drug already approved for other purposes can apparently render this weapon harmless.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
Your Benefits
- Access to all content
- Receive newsmails for news and jobs
- Post ads
